Hero or Villain – Are SGLT2 Inhibitors Your Patients’ BFF or Something to Be Cautious Of?

Hero or Villain – Are SGLT2 Inhibitors Your Patients’ BFF or Something to Be Cautious Of?

Hero or Villain – Are SGLT2 Inhibitors Your Patients’ BFF or Something to Be Cautious Of?

Lessons from Current Guidelines and ASN

Speakers: Professor Sophia Zoungas, Professor Carmel Hawley, Professor Karen Dwyer, Dr Brendan Smyth and Dr Melinda TeeDate: 18 November 2021


Webinar Search

Webinar Categories

Disclaimer: This webpage including the open access webinars is intended for use by healthcare professionals only. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.

ADS Professional Education Webinars

Disclaimer Notice

By agreeing to this disclaimer notice; you acknowledge that you are a registered healthcare professional accessing the open access clinical educational webinars hosted by the Australian Diabetes Society. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.